Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

FDA updates labeling for ACETAMINOPHEN AND CODEINE PHOSPHATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 5
  • 0 comments

Labeling changes approved for PAI HOLDINGS. Active ingredient: ACETAMINOPHEN; CODEINE PHOSPHATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for MORPHINE SULFATE

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 4
  • 0 comments

Labeling changes approved for HIKMA. Active ingredient: MORPHINE SULFATE. Decision date: 12/22/2025

Comment Full text

FDA updates labeling for BUTRANS

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 5
  • 0 comments

Labeling changes approved for PURDUE PHARMA LP. Active ingredient: BUPRENORPHINE. Decision date: 12/22/2025

Comment Full text

FDA regulatory update for Xeomin

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 10
  • 0 comments

Administrative update #SUPPL-106 for MERZ PHARMS. Status: Approval. Decision date: 12/17/2025

Comment Full text

FDA updates labeling for HYDROCODONE BITARTRATE AND ACETAMINOPHEN

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 5
  • 0 comments

Labeling changes approved for PRINSTON INC. Active ingredient: ACETAMINOPHEN; HYDROCODONE BITARTRATE. Decision date: 12/15/2025

Comment Full text

FDA updates labeling for ORILISSA

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 4
  • 0 comments

Labeling changes approved for ABBVIE. Active ingredient: ELAGOLIX SODIUM. Decision date: 12/17/2025

Comment Full text

FDA regulatory update for ABRILADA

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 4
  • 0 comments

Administrative update #SUPPL-20 for PFIZER INC. Status: Approval. Decision date: 12/17/2025

Comment Full text

FDA grants tentative approval for DAPAGLIFLOZIN from TEVA PHARMS USA INC

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 0
  • 0 comments

Tentative approval of ANDA #ANDA #211541 for DAPAGLIFLOZIN. Decision date: 12/18/2025

Comment Full text

FDA approves BORTEZOMIB from SHUANGCHENG

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 5
  • 0 comments

Final approval of ANDA #ANDA #216528 for BORTEZOMIB. Decision date: 12/17/2025

Comment Full text

FDA regulatory update for LEQEMBI

  • FDA Approval
  • Dec. 31, 2025, 13:45 UTC
  • 7
  • 0 comments

Administrative update #SUPPL-12 for EISAI INC. Status: Approval. Decision date: 12/15/2025

Comment Full text
  • Previous
  • 27
  • 28
  • 29
  • 30
  • 31
  • Next

Search

News categories

  • Technical Exchange News(10866)
  • Event(2237)
  • SEC News(188819)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124439)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin